Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 905–912 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
BioAtla Inc. Mecbotamab Vedotin (BA3011) Solid Tumors Phase 2 Trial Completed Intravenous Oncology
BioCardia Inc. CardiAMP (Heart Failure II) Ischemic heart failure of reduced ejection fraction (HFrEF) Phase 3 Ongoing Intracoronary Cardiology
BioCardia Inc. CardiAMP (BCDA-02) Chronic Myocardial Ischemia Phase 3 Data Released Intracoronary Cardiology
BioCardia Inc. CardiAMP (BCDA-01) Ischemic Heart Failure Phase 3 Ongoing Intracoronary Cardiology
BioCryst Pharmaceuticals Inc. BCX4161 - (OPuS-2) Hereditary angioedema Phase 2b Trial Discontinued Oral Genetic Disorder
BioCryst Pharmaceuticals Inc. BCX9930 - (RENEW) Renal Complement-mediated Diseases Phase 2 Trial Discontinued oral Immunology
BioCryst Pharmaceuticals Inc. BCX9930 - (REDEEM-2) Paroxysmal nocturnal hemoglobinuria (PNH) Phase 2 Trial Discontinued Oral Hematology
BioCryst Pharmaceuticals Inc. BCX9930 - (REDEEM-1) Paroxysmal nocturnal hemoglobinuria (PNH) Phase 3 Trial Discontinued Oral Hematology